Ingrid Kohut, DO
Hematology, Medical Oncology

Ingrid Kohut, DO

Hematology, Medical Oncology
Accepting new patients
Sees patients age 18 and up
Penn Hematology/Oncology Pennsylvania Hospital
View 1 additional location
Penn Medicine Provider

About me

  • Clinical Associate Professor of Medicine (Hematology-Oncology)

My education and training

  • Philadelphia College of Osteopathic MedicineMedical School
  • Temple University HospitalResidency
  • Drexel UniversityResidency
  • Drexel UniversityFellowship

Spoken languages

English
English

Reviews

Average Rating

994 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
September 2026
Very kind
Anonymous
September 2026
Honestly I am never certain what the results could be since Dr.Kohut is a specialist and anything can occur during the year between visits. I am confident and at ease whenever I see Dr.K. I truly feel that I'm in good hands.
Anonymous
September 2026
Provided good feedback and plan for care.
Anonymous
September 2026
She explained everything in layman's terms and was very nice. Appointment did not feel rushed.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Kohut is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

E.S. Kim, B. Halmos, I. F. Kohut, T. Patel, R.D. Rostorfer, A.I. Spira, A. Cseh, J. McKay, G.Wallenstein, K.F. Mileham. Results of the Afatinib Expanded Access Program (EAP): Safety and Efficacy. Poster #182 , Presented at the Chicago Multidisciplinary Symposium in Thoracic Oncology, October 30-November 1, 2014.: 2014


Warsame R. Kohut IE. Dispenzieri A. Successful use of cyclophosphamide, bortezomib, and dexamethasone to treat a case of relapsed POEMS. , European Journal of Haematology, 88(6): 2012,549-50